Guggenheim Maintains Buy on GeneDx Holdings, Raises Price Target to $74
Guggenheim analyst Subbu Nambi maintains GeneDx Holdings (NASDAQ: WGS ) with a Buy and raises the price target from $70 to $74.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.